{"id":354255,"date":"2025-08-28T11:53:02","date_gmt":"2025-08-28T11:53:02","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-ideaya-biosciences\/"},"modified":"2025-08-28T11:53:02","modified_gmt":"2025-08-28T11:53:02","slug":"how-to-buy-ideaya-biosciences","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","title":{"rendered":"How to buy IDEAYA Biosciences, Inc. (IDYA) shares &#8211; Investment in IDEAYA Biosciences, Inc. (IDYA) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334099,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354255","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy IDEAYA Biosciences, Inc. (IDYA) Shares - Investment in IDEAYA Biosciences, Inc. (IDYA) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy IDEAYA Biosciences, Inc. (IDYA) Shares - Investment in IDEAYA Biosciences, Inc. (IDYA) Stock"},"description":"Learn how to buy IDEAYA Biosciences, Inc. (IDYA) shares and invest in this precision medicine oncology company. Discover current stock performance, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy IDEAYA Biosciences, Inc. (IDYA) shares and invest in this precision medicine oncology company. Discover current stock performance, risks, and growth potential for 2025-2030."},"intro":"Want to invest in the future of cancer treatment? IDEAYA Biosciences represents the cutting edge of precision medicine oncology\u2014where targeted therapies meet genetic breakthroughs. This clinical-stage biotech company could revolutionize how we treat cancer, making it an exciting opportunity for forward-thinking investors. Let's explore why IDYA stock deserves your attention and how you can become part of this medical innovation story.","intro_source":{"label":"Intro","type":"text","formatted_value":"Want to invest in the future of cancer treatment? IDEAYA Biosciences represents the cutting edge of precision medicine oncology\u2014where targeted therapies meet genetic breakthroughs. This clinical-stage biotech company could revolutionize how we treat cancer, making it an exciting opportunity for forward-thinking investors. Let's explore why IDYA stock deserves your attention and how you can become part of this medical innovation story."},"body_html":"<h2>\ud83d\udcc8 IDEAYA Biosciences Stock: Current Price and Critical Dates<\/h2> <p>As of August 28, 2025, IDEAYA Biosciences (IDYA) trades at <strong>$25.00<\/strong> on the NASDAQ exchange. The stock has shown remarkable resilience, bouncing back from its 52-week low of $13.45 and demonstrating strong momentum with a 29.35% gain over the past three months.<\/p> <p><strong>Mark Your Calendar: November 3, 2025<\/strong> is the next critical date every IDYA investor should watch. This is when the company releases its Q3 2025 earnings report\u2014a potential catalyst that could significantly move the stock price.<\/p> <h3>How Earnings Reports Impact IDYA Stock<\/h3> <p>Looking at recent history reveals a clear pattern. When IDEAYA announced its Q2 2025 results on August 5, 2025, the market responded positively to their robust cash position of $992 million and strong clinical trial progress. The stock has gained approximately 9% in the two weeks following that announcement.<\/p> <p>Previous earnings events show similar patterns:<\/p> <ul> <li><strong>May 2025 Q1 Results<\/strong>: Stock gained 6% in the week following the $1.05 billion cash position announcement<\/li> <li><strong>February 2025 Annual Report<\/strong>: Positive 8% movement after highlighting pipeline advancements<\/li> <li><strong>November 2024 Update<\/strong>: Modest 3% gain following clinical trial enrollment milestones<\/li> <\/ul> <p>The pattern is clear\u2014positive clinical updates and strong financial positioning consistently drive investor confidence in this biotech innovator.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey: From Volatility to Stability<\/h2> <p>IDEAYA's stock has taken investors on quite a ride over the past six months. Here's how the journey unfolded:<\/p> <p><strong>March 2025<\/strong>: Trading around $19.50 after market uncertainty<br\/> <strong>April 2025<\/strong>: Climbed to $22.80 on positive Phase 2 data announcements<br\/> <strong>May 2025<\/strong>: Surged to $25.50 following Q1 earnings and cash runway guidance<br\/> <strong>June 2025<\/strong>: Consolidated around $24.20 during summer trading<br\/> <strong>July 2025<\/strong>: Reached $26.80 on FDA breakthrough therapy designation news<br\/> <strong>August 2025<\/strong>: Currently at $25.00 with stable weekly volatility of just 6.2%<\/p> <p>What's driving this recovery? Several factors:<\/p> <ul> <li>Successful enrollment of over 350 patients in key clinical trials<\/li> <li>FDA breakthrough therapy designation for darovasertib<\/li> <li>Strong cash position funding operations into 2029<\/li> <li>Multiple IND submissions planned for late 2025<\/li> <\/ul> <p>The stock's low beta of 0.086 means it moves independently of broader market swings\u2014perfect for investors seeking biotechnology exposure without excessive market correlation.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst consensus and clinical milestones, here's what to expect:<\/p> <p><strong>2025 Year-End Target<\/strong>: $30-35 range (20-40% upside from current levels)<br\/> Analysts project a 24.24% rise over the next three months, with a 90% probability range of $26.09-$30.95. The upcoming R&D Day on September 8th could be a significant catalyst.<\/p> <p><strong>2026 Projection<\/strong>: $45-50 average target<br\/> With multiple clinical readouts expected and potential regulatory submissions, 2026 could be a breakthrough year. Conservative estimates target $47.94 while optimistic forecasts reach $80.38.<\/p> <p><strong>2028 Outlook<\/strong>: $60-70 range<br\/> By 2028, several key programs could be commercialized or in late-stage development, driving substantial value creation.<\/p> <p><strong>2030 Vision<\/strong>: $70-85 potential<br\/> Long-term analysts project $73.44 by 2030 as the company potentially transforms from clinical-stage to commercial-stage biotech.<\/p> <p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. The combination of robust cash runway, multiple clinical catalysts, and first-in-class pipeline makes IDYA an attractive investment at current levels.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Clinical Trial Failures<\/strong>: Biotech stocks live and die by clinical data. Any negative results from ongoing trials could significantly impact the stock price.<\/li> <li><strong>Regulatory Hurdles<\/strong>: FDA approvals are never guaranteed. Delays or rejections could set back development timelines.<\/li> <li><strong>Market Volatility<\/strong>: While IDYA has low beta, biotech sector sentiment can shift rapidly based on macroeconomic factors.<\/li> <li><strong>Competition<\/strong>: Other companies are developing similar precision medicine approaches, though IDEAYA's synthetic lethality focus provides some differentiation.<\/li> <\/ul> <h3>Green Lights for 2025-2026<\/h3> <ul> <li><strong>Cash Runway Advantage<\/strong>: With $1.05 billion cash position funding operations into 2029, IDEAYA has minimal dilution risk\u2014a rare advantage in biotech.<\/li> <li><strong>Multiple Catalysts<\/strong>: The company has over 300 patients treated across studies with several data readouts expected by year-end 2025.<\/li> <li><strong>FDA Breakthrough Status<\/strong>: Darovasertib's breakthrough therapy designation accelerates regulatory review and increases approval probability.<\/li> <li><strong>Industry Tailwinds<\/strong>: Precision medicine oncology is experiencing massive growth, with the market expected to exceed $100 billion by 2030.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start Small<\/strong>: Begin with a position size that represents no more than 2-3% of your total portfolio. Biotech investing requires patience and risk management.<\/li> <li><strong>Dollar-Cost Average<\/strong>: Instead of buying all at once, consider spreading your purchases over several weeks to average your entry price.<\/li> <li><strong>Set Price Alerts<\/strong>: Monitor key levels around $23 (support) and $27 (resistance) for optimal entry points.<\/li> <li><strong>Follow the Science<\/strong>: Track clinical trial updates rather than daily price movements. The real value drivers are medical breakthroughs, not market sentiment.<\/li> <\/ol> <p>And my favorite trader wisdom: \"Investing in biotech is like watching paint dry\u2014except sometimes the paint cures cancer and makes you rich. Patience isn't just a virtue; it's a profit strategy.\"<\/p> <h2>\u2705 How to Buy IDEAYA Biosciences, Inc. (IDYA) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a Trading Platform<\/td><td>Ensure it offers NASDAQ-listed stocks and has reasonable commission fees<\/td><\/tr> <tr><td>2<\/td><td>Open and Fund Your Account<\/td><td>Start with an amount you're comfortable risking\u2014even $100 can get you started<\/td><\/tr> <tr><td>3<\/td><td>Search for \"IDYA\"<\/td><td>Use the ticker symbol, not just the company name, to find the correct security<\/td><\/tr> <tr><td>4<\/td><td>Select Order Type<\/td><td>Use limit orders to control your entry price rather than market orders<\/td><\/tr> <tr><td>5<\/td><td>Review and Confirm<\/td><td>Double-check order details including quantity, price, and total cost<\/td><\/tr> <tr><td>6<\/td><td>Monitor Your Position<\/td><td>Set up alerts for earnings dates and clinical trial announcements<\/td><\/tr> <tr><td>7<\/td><td>Consider Dividend Reinvestment<\/td><td>While IDYA doesn't pay dividends currently, plan for future growth<\/td><\/tr> <tr><td>8<\/td><td>Track Performance<\/td><td>Use portfolio tracking tools to monitor your investment over time<\/td><\/tr> <tr><td>9<\/td><td>Stay Informed<\/td><td>Follow company press releases and clinical updates regularly<\/td><\/tr> <tr><td>10<\/td><td>Review Strategy Quarterly<\/td><td>Reassess your position based on new developments and overall portfolio goals<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Stands Out for New Investors<\/h2> <p>For those beginning their investment journey, Pocket Option offers several advantages that make accessing stocks like IDYA straightforward:<\/p> <ul> <li><strong>Minimal Barrier to Entry<\/strong>: With just a $5 minimum deposit, you can start building positions in promising companies without significant capital commitment.<\/li> <li><strong>Streamlined Verification<\/strong>: The platform's 1-minute KYC process using any single document means you can begin trading almost immediately after registration.<\/li> <li><strong>Diverse Withdrawal Options<\/strong>: Over 100 withdrawal methods including cryptocurrencies, e-wallets, and traditional bank transfers provide flexibility in managing your profits.<\/li> <li><strong>Educational Resources<\/strong>: The Pocket Option blog offers valuable insights for investors looking to expand their knowledge beyond basic trading.<\/li> <\/ul> <h2>\ud83c\udf0d IDEAYA Biosciences in 2025: Precision Medicine Pioneer<\/h2> <p>IDEAYA Biosciences stands at the forefront of a medical revolution. The company specializes in synthetic lethality\u2014an innovative approach that targets cancer cells based on their genetic vulnerabilities rather than broad-based toxicity. With over 300 patients already treated in their clinical trials and multiple programs advancing simultaneously, IDEAYA represents the future of oncology treatment.<\/p> <p>The company's $1.05 billion cash position provides unprecedented financial stability for a clinical-stage biotech, funding operations well into 2029. This eliminates the typical dilution risk that plagues many emerging pharmaceutical companies.<\/p> <p><strong>Interesting Fact<\/strong>: In celebration of their 10-year anniversary in 2025, IDEAYA installed interactive digital walls at their South San Francisco headquarters that display real-time clinical trial data\u2014allowing scientists to literally watch cancer research unfold before their eyes as patient responses come in from around the world.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 IDEAYA Biosciences Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 28, 2025, IDEAYA Biosciences (IDYA) trades at <strong>$25.00<\/strong> on the NASDAQ exchange. The stock has shown remarkable resilience, bouncing back from its 52-week low of $13.45 and demonstrating strong momentum with a 29.35% gain over the past three months.<\/p>\n<p><strong>Mark Your Calendar: November 3, 2025<\/strong> is the next critical date every IDYA investor should watch. This is when the company releases its Q3 2025 earnings report\u2014a potential catalyst that could significantly move the stock price.<\/p>\n<h3>How Earnings Reports Impact IDYA Stock<\/h3>\n<p>Looking at recent history reveals a clear pattern. When IDEAYA announced its Q2 2025 results on August 5, 2025, the market responded positively to their robust cash position of $992 million and strong clinical trial progress. The stock has gained approximately 9% in the two weeks following that announcement.<\/p>\n<p>Previous earnings events show similar patterns:<\/p>\n<ul>\n<li><strong>May 2025 Q1 Results<\/strong>: Stock gained 6% in the week following the $1.05 billion cash position announcement<\/li>\n<li><strong>February 2025 Annual Report<\/strong>: Positive 8% movement after highlighting pipeline advancements<\/li>\n<li><strong>November 2024 Update<\/strong>: Modest 3% gain following clinical trial enrollment milestones<\/li>\n<\/ul>\n<p>The pattern is clear\u2014positive clinical updates and strong financial positioning consistently drive investor confidence in this biotech innovator.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey: From Volatility to Stability<\/h2>\n<p>IDEAYA&#8217;s stock has taken investors on quite a ride over the past six months. Here&#8217;s how the journey unfolded:<\/p>\n<p><strong>March 2025<\/strong>: Trading around $19.50 after market uncertainty<br \/> <strong>April 2025<\/strong>: Climbed to $22.80 on positive Phase 2 data announcements<br \/> <strong>May 2025<\/strong>: Surged to $25.50 following Q1 earnings and cash runway guidance<br \/> <strong>June 2025<\/strong>: Consolidated around $24.20 during summer trading<br \/> <strong>July 2025<\/strong>: Reached $26.80 on FDA breakthrough therapy designation news<br \/> <strong>August 2025<\/strong>: Currently at $25.00 with stable weekly volatility of just 6.2%<\/p>\n<p>What&#8217;s driving this recovery? Several factors:<\/p>\n<ul>\n<li>Successful enrollment of over 350 patients in key clinical trials<\/li>\n<li>FDA breakthrough therapy designation for darovasertib<\/li>\n<li>Strong cash position funding operations into 2029<\/li>\n<li>Multiple IND submissions planned for late 2025<\/li>\n<\/ul>\n<p>The stock&#8217;s low beta of 0.086 means it moves independently of broader market swings\u2014perfect for investors seeking biotechnology exposure without excessive market correlation.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst consensus and clinical milestones, here&#8217;s what to expect:<\/p>\n<p><strong>2025 Year-End Target<\/strong>: $30-35 range (20-40% upside from current levels)<br \/> Analysts project a 24.24% rise over the next three months, with a 90% probability range of $26.09-$30.95. The upcoming R&#038;D Day on September 8th could be a significant catalyst.<\/p>\n<p><strong>2026 Projection<\/strong>: $45-50 average target<br \/> With multiple clinical readouts expected and potential regulatory submissions, 2026 could be a breakthrough year. Conservative estimates target $47.94 while optimistic forecasts reach $80.38.<\/p>\n<p><strong>2028 Outlook<\/strong>: $60-70 range<br \/> By 2028, several key programs could be commercialized or in late-stage development, driving substantial value creation.<\/p>\n<p><strong>2030 Vision<\/strong>: $70-85 potential<br \/> Long-term analysts project $73.44 by 2030 as the company potentially transforms from clinical-stage to commercial-stage biotech.<\/p>\n<p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. The combination of robust cash runway, multiple clinical catalysts, and first-in-class pipeline makes IDYA an attractive investment at current levels.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Clinical Trial Failures<\/strong>: Biotech stocks live and die by clinical data. Any negative results from ongoing trials could significantly impact the stock price.<\/li>\n<li><strong>Regulatory Hurdles<\/strong>: FDA approvals are never guaranteed. Delays or rejections could set back development timelines.<\/li>\n<li><strong>Market Volatility<\/strong>: While IDYA has low beta, biotech sector sentiment can shift rapidly based on macroeconomic factors.<\/li>\n<li><strong>Competition<\/strong>: Other companies are developing similar precision medicine approaches, though IDEAYA&#8217;s synthetic lethality focus provides some differentiation.<\/li>\n<\/ul>\n<h3>Green Lights for 2025-2026<\/h3>\n<ul>\n<li><strong>Cash Runway Advantage<\/strong>: With $1.05 billion cash position funding operations into 2029, IDEAYA has minimal dilution risk\u2014a rare advantage in biotech.<\/li>\n<li><strong>Multiple Catalysts<\/strong>: The company has over 300 patients treated across studies with several data readouts expected by year-end 2025.<\/li>\n<li><strong>FDA Breakthrough Status<\/strong>: Darovasertib&#8217;s breakthrough therapy designation accelerates regulatory review and increases approval probability.<\/li>\n<li><strong>Industry Tailwinds<\/strong>: Precision medicine oncology is experiencing massive growth, with the market expected to exceed $100 billion by 2030.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start Small<\/strong>: Begin with a position size that represents no more than 2-3% of your total portfolio. Biotech investing requires patience and risk management.<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Instead of buying all at once, consider spreading your purchases over several weeks to average your entry price.<\/li>\n<li><strong>Set Price Alerts<\/strong>: Monitor key levels around $23 (support) and $27 (resistance) for optimal entry points.<\/li>\n<li><strong>Follow the Science<\/strong>: Track clinical trial updates rather than daily price movements. The real value drivers are medical breakthroughs, not market sentiment.<\/li>\n<\/ol>\n<p>And my favorite trader wisdom: &#8220;Investing in biotech is like watching paint dry\u2014except sometimes the paint cures cancer and makes you rich. Patience isn&#8217;t just a virtue; it&#8217;s a profit strategy.&#8221;<\/p>\n<h2>\u2705 How to Buy IDEAYA Biosciences, Inc. (IDYA) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NASDAQ-listed stocks and has reasonable commission fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Open and Fund Your Account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking\u2014even $100 can get you started<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search for &#8220;IDYA&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name, to find the correct security<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select Order Type<\/td>\n<td>Use limit orders to control your entry price rather than market orders<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and Confirm<\/td>\n<td>Double-check order details including quantity, price, and total cost<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Monitor Your Position<\/td>\n<td>Set up alerts for earnings dates and clinical trial announcements<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Consider Dividend Reinvestment<\/td>\n<td>While IDYA doesn&#8217;t pay dividends currently, plan for future growth<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Track Performance<\/td>\n<td>Use portfolio tracking tools to monitor your investment over time<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Stay Informed<\/td>\n<td>Follow company press releases and clinical updates regularly<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Review Strategy Quarterly<\/td>\n<td>Reassess your position based on new developments and overall portfolio goals<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Stands Out for New Investors<\/h2>\n<p>For those beginning their investment journey, Pocket Option offers several advantages that make accessing stocks like IDYA straightforward:<\/p>\n<ul>\n<li><strong>Minimal Barrier to Entry<\/strong>: With just a $5 minimum deposit, you can start building positions in promising companies without significant capital commitment.<\/li>\n<li><strong>Streamlined Verification<\/strong>: The platform&#8217;s 1-minute KYC process using any single document means you can begin trading almost immediately after registration.<\/li>\n<li><strong>Diverse Withdrawal Options<\/strong>: Over 100 withdrawal methods including cryptocurrencies, e-wallets, and traditional bank transfers provide flexibility in managing your profits.<\/li>\n<li><strong>Educational Resources<\/strong>: The Pocket Option blog offers valuable insights for investors looking to expand their knowledge beyond basic trading.<\/li>\n<\/ul>\n<h2>\ud83c\udf0d IDEAYA Biosciences in 2025: Precision Medicine Pioneer<\/h2>\n<p>IDEAYA Biosciences stands at the forefront of a medical revolution. The company specializes in synthetic lethality\u2014an innovative approach that targets cancer cells based on their genetic vulnerabilities rather than broad-based toxicity. With over 300 patients already treated in their clinical trials and multiple programs advancing simultaneously, IDEAYA represents the future of oncology treatment.<\/p>\n<p>The company&#8217;s $1.05 billion cash position provides unprecedented financial stability for a clinical-stage biotech, funding operations well into 2029. This eliminates the typical dilution risk that plagues many emerging pharmaceutical companies.<\/p>\n<p><strong>Interesting Fact<\/strong>: In celebration of their 10-year anniversary in 2025, IDEAYA installed interactive digital walls at their South San Francisco headquarters that display real-time clinical trial data\u2014allowing scientists to literally watch cancer research unfold before their eyes as patient responses come in from around the world.<\/p>\n"},"faq":[{"question":"What makes IDEAYA Biosciences different from other biotech companies?","answer":"IDEAYA focuses on synthetic lethality and precision medicine, targeting specific genetic vulnerabilities in cancer cells rather than using broad-based approaches. Their integrated biomarker discovery and drug development platform is particularly innovative."},{"question":"How risky is investing in a clinical-stage biotech company?","answer":"Higher risk than established companies, but IDEAYA's $1.05 billion cash position significantly reduces financial risk. The main risks involve clinical trial outcomes and regulatory approvals."},{"question":"When might IDEAYA become profitable?","answer":"Most analysts project potential profitability in the 2027-2028 timeframe if key drugs receive FDA approval and achieve commercial success."},{"question":"Does IDEAYA pay dividends?","answer":"No, as a clinical-stage company, IDEAYA reinvests all capital into research and development rather than paying dividends to shareholders."},{"question":"What percentage of my portfolio should be in biotech stocks like IDYA?","answer":"Most financial advisors recommend limiting biotech exposure to 5-10% of a diversified portfolio due to the sector's inherent volatility and binary outcomes."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What makes IDEAYA Biosciences different from other biotech companies?","answer":"IDEAYA focuses on synthetic lethality and precision medicine, targeting specific genetic vulnerabilities in cancer cells rather than using broad-based approaches. Their integrated biomarker discovery and drug development platform is particularly innovative."},{"question":"How risky is investing in a clinical-stage biotech company?","answer":"Higher risk than established companies, but IDEAYA's $1.05 billion cash position significantly reduces financial risk. The main risks involve clinical trial outcomes and regulatory approvals."},{"question":"When might IDEAYA become profitable?","answer":"Most analysts project potential profitability in the 2027-2028 timeframe if key drugs receive FDA approval and achieve commercial success."},{"question":"Does IDEAYA pay dividends?","answer":"No, as a clinical-stage company, IDEAYA reinvests all capital into research and development rather than paying dividends to shareholders."},{"question":"What percentage of my portfolio should be in biotech stocks like IDYA?","answer":"Most financial advisors recommend limiting biotech exposure to 5-10% of a diversified portfolio due to the sector's inherent volatility and binary outcomes."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy IDEAYA Biosciences, Inc. (IDYA) shares - Investment in IDEAYA Biosciences, Inc. (IDYA) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy IDEAYA Biosciences, Inc. (IDYA) shares - Investment in IDEAYA Biosciences, Inc. (IDYA) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T11:53:02+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy IDEAYA Biosciences, Inc. (IDYA) shares &#8211; Investment in IDEAYA Biosciences, Inc. (IDYA) stock\",\"datePublished\":\"2025-08-28T11:53:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\",\"name\":\"How to buy IDEAYA Biosciences, Inc. (IDYA) shares - Investment in IDEAYA Biosciences, Inc. (IDYA) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"datePublished\":\"2025-08-28T11:53:02+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy IDEAYA Biosciences, Inc. (IDYA) shares &#8211; Investment in IDEAYA Biosciences, Inc. (IDYA) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy IDEAYA Biosciences, Inc. (IDYA) shares - Investment in IDEAYA Biosciences, Inc. (IDYA) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","og_locale":"en_US","og_type":"article","og_title":"How to buy IDEAYA Biosciences, Inc. (IDYA) shares - Investment in IDEAYA Biosciences, Inc. (IDYA) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T11:53:02+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy IDEAYA Biosciences, Inc. (IDYA) shares &#8211; Investment in IDEAYA Biosciences, Inc. (IDYA) stock","datePublished":"2025-08-28T11:53:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","name":"How to buy IDEAYA Biosciences, Inc. (IDYA) shares - Investment in IDEAYA Biosciences, Inc. (IDYA) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","datePublished":"2025-08-28T11:53:02+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy IDEAYA Biosciences, Inc. (IDYA) shares &#8211; Investment in IDEAYA Biosciences, Inc. (IDYA) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":354308,"slug":"how-to-buy-ideaya-biosciences","post_title":"Comment acheter des actions IDEAYA Biosciences, Inc. (IDYA) - Investir dans les actions IDEAYA Biosciences, Inc. (IDYA)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"it_IT":{"locale":"it_IT","id":354310,"slug":"how-to-buy-ideaya-biosciences","post_title":"Come acquistare azioni IDEAYA Biosciences, Inc. (IDYA) - Investire in azioni IDEAYA Biosciences, Inc. (IDYA)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"pl_PL":{"locale":"pl_PL","id":354312,"slug":"how-to-buy-ideaya-biosciences","post_title":"Jak kupi\u0107 akcje IDEAYA Biosciences, Inc. (IDYA) - Inwestycja w akcje IDEAYA Biosciences, Inc. (IDYA)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"es_ES":{"locale":"es_ES","id":354314,"slug":"how-to-buy-ideaya-biosciences","post_title":"C\u00f3mo comprar acciones de IDEAYA Biosciences, Inc. (IDYA) - Inversi\u00f3n en acciones de IDEAYA Biosciences, Inc. (IDYA)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"th_TH":{"locale":"th_TH","id":354313,"slug":"how-to-buy-ideaya-biosciences","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 IDEAYA Biosciences, Inc. (IDYA) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 IDEAYA Biosciences, Inc. (IDYA)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"tr_TR":{"locale":"tr_TR","id":354311,"slug":"how-to-buy-ideaya-biosciences","post_title":"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"vt_VT":{"locale":"vt_VT","id":354315,"slug":"how-to-buy-ideaya-biosciences","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu IDEAYA Biosciences, Inc. (IDYA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu IDEAYA Biosciences, Inc. (IDYA)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"pt_AA":{"locale":"pt_AA","id":354309,"slug":"how-to-buy-ideaya-biosciences","post_title":"Como comprar a\u00e7\u00f5es da IDEAYA Biosciences, Inc. (IDYA) - Investimento em a\u00e7\u00f5es da IDEAYA Biosciences, Inc. (IDYA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/354255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=354255"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/354255\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334099"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=354255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=354255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=354255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}